![4-[(4-Methylpiperazin-1-yl)methyl]acidi dihydrochloridi benzoici CAS NO.106261-49-8 Image](http://cdn.globalso.com/shlzpharma/106261-49-8-1.jpg)
![4-[(4-Methylpiperazin-1-yl) methyl]acidi dihydrochloridi benzoici CAS NO.106261-49-8](http://cdn.globalso.com/shlzpharma/106261-49-8-2.jpg)
4-[(4-Methylpiperazin-1-yl) methyl]acidi dihydrochloridi benzoici CAS NO.106261-49-8
| Nomen | 4-[(4-Methylpiperazin-1-yl) methyl]acidi dihydrochloridi benzoici | ||
| CAS NO. | 106261-49-8 | ||
| Formulae hypotheticae | C13H20Cl2N2O2 | M. Pondus | 307.22 |
| MDL No. | MCD08060469 | EINECS | 600-728-4 |
| MP | 305-307°C | BP | NA |
| Densitas | NA | Index refractivus | NA |
| FP | NA | Repono conditione | Iners aer, locus Temperature |
|
| |||
| Aspectus | album ut off-alba crystallum pulveris | ||
| Puritas | 98% | ||
| Applicationem | Imatinib medium | ||
| Facultates copia | 4-[(4-Methylpiperazin-1-yl) methyl] acidum benzoicum dihydrochloridum CAS NO.106261-49-8 productio nostra regulariter est, sive parva sample sive magna oneraria plus quam tonnagium indigeas, nostra societas eam supplere potest. formally | ||
| Si interest in 4-[(4-Methylpiperazin-1-yl)methyl]acidi dihydrochloridi benzoici CAS NO.106261-49-8, libenter nos tange, quaeso, et praestabimus tibi optimam qualitatem productorum, rationabili pretio ac optimum servitium expectans cooperationem. | |
| | |
| Phone No. | +86 139 6251 3054 +86 136 2174 3828 |
Producta, quae a consortio recensentur, patentes implicant, quae tantum ad investigationes et progressus et non venales sunt;fructus moderati vendentur stricte obsequio cum legibus Sinensium et legibus regionis ubi mercantur, et omnia producta usui humano non apta sunt.Si venditae patentes praeiudicium constituent, omnia pericula ab emptore ferentur.
![5-[4-((3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)amino)quinazolin-6-yl]-2-furaldehyde CAS NO.231278-84-5](http://cdn.globalso.com/shlzpharma/117.png)
![(7a,17b)-7-[9-[(4,4,5,5,5-Pentafluorpentyl)Thio]Nonyl]-Estra-1,3,5(10)-Triene-3,17-Diol 17- ACETATIS CAS NO.875573-69-6](http://cdn.globalso.com/shlzpharma/127.png)
